Publications

Explore our research outputs and impact in-depth.

Engineered antibodies to combat viral threats

Mark Cragg & Xiaojie Yu, 2020, Nature, 588, 398-399

Type: article

Tumor-resident stromal cells promote breast cancer Invasion through regulation of the basal phenotype

Christopher Hanley, Elodie Henriet, Orit Katarina Sirka, Gareth Thomas & Andrew Ewald, 2020, Molecular cancer research : MCR, 18(11), 1615–1622

DOI: 10.1158/1541-7786.mcr-20-0334

Type: article

Immune characterization of pre-clinical murine models of neuroblastoma

Emily Webb, Silvia Lanati, Carol Wareham, Alistair Easton, Stuart N. Dunn, Tatyana Inzhelevskaya, Freja M. Sadler, Sonya James, Margaret Ashton-Key, Mark Cragg, Stephen Beers & Juliet Gray, 2020, Scientific Reports, 10(1)

DOI: 10.1038/s41598-020-73695-9

Type: article

LILRB3 (ILT5) is a myeloid cell checkpoint that elicits profound immunomodulation

Muchaala Yeboah, Charys Papagregoriou, Des C. Jones, Hak Chan, Guangan Hu, Justine McPartlan, Christopher Mockridge, Ivo Tews, Martin Glennie, Stephen Thirdborough, Mark Cragg & Ali Roghanian, 2020, JCI Insight, 5(18)

DOI: 10.1172/jci.insight.141593

Type: article

NOX4 inhibition potentiates immunotherapy by overcoming cancer-associated fibroblast-mediated CD8 T-cell exclusion from tumors

K. Ford, C.J. Hanley, M. Mellone, C. Szyndralewiez, F. Heitz, P. Wiesel, O. Wood, M. Machado, M.-A. Lopez, A.-P. Ganesan, C. Wang, A. Chakravarthy, T.R. Fenton, E.V. King, P. Vijayanand, C.H. Ottensmeier, A. Al-Shamkhani, N. Savelyeva & G.J. Thomas, 2020, Cancer Research, 80(9), 1846-1860

DOI: 10.1158/0008-5472.CAN-19-3158

Type: article